Search - tctmd.com

Displaying 181 - 200 of 526

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Marcus A. Banks

June 24, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Daily News

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Caitlin E. Cox

June 12, 2019

News Daily News

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

Todd Neale

June 03, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

Todd Neale

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Lucy Hicks

February 15, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

In-Hospital Acute MI: Despite Numerous Predictors, Solutions Remain Elusive

Caitlin E. Cox

January 18, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for June 2019

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

TCTMD’s Top 10 Most Popular Stories for February 2019

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Quality of CAD Care Varies by Type of Medicare Coverage

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

One in Two Americans Have Cardiovascular Disease: AHA Stats

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

In-Hospital Acute MI: Despite Numerous Predictors, Solutions Remain Elusive

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content